Status:

ENROLLING_BY_INVITATION

SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy

Lead Sponsor:

Allina Health System

Conditions:

Chemotherapy-induced Peripheral Neuropathy

Eligibility:

All Genders

45+ years

Phase:

NA

Brief Summary

The main purpose of this study is to determine the threshold level of lower extremity CIPN symptoms that put patients who have been prescribed a neurotoxic chemotherapy agent (e.g., paclitaxel, doceta...

Detailed Description

Patients who are treated with neurotoxic chemotherapy as part of their cancer treatment regimen often experience lower extremity chemotherapy-induced peripheral neuropathy (CIPN) that causes motor and...

Eligibility Criteria

Inclusion

  • ≥ 45 years old
  • New cancer diagnosis other than a primary brain tumor
  • A taxane and/or platinum chemotherapy agent has been prescribed as part of the treatment regimen for cancer.
  • English speaking
  • Able to see, hear, speak (with or without assistive devices)
  • Able to walk without an assistive device - for example: cane, walker, walking stick(s) at the start of cancer treatment
  • Able to provide own transportation to study visits
  • Willing and able to commit to symptom tracking three times weekly via mEMA for up to 9 months.
  • Owns a smartphone with one of the following operating system versions:
  • iOS 8.0 - 8.4, 9.0 - 9.3, 10.0 - 10.3, 12, 13.3 or later Android 7.0 - 7.1.2, 8.0 - 8.1.0, 9, 10 or later
  • Agree to use personal smartphone to download the mEMA application and respond to application notifications.

Exclusion

  • Individuals who started their chemotherapy regimen greater than 4 weeks prior to study enrollment.
  • Individuals being treated for a primary brain tumor

Key Trial Info

Start Date :

January 3 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 3 2027

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05330104

Start Date

January 3 2022

End Date

January 3 2027

Last Update

July 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Abbott Northwestern Hospital

Minneapolis, Minnesota, United States, 55447

SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy | DecenTrialz